Skip to search formSkip to main contentSkip to account menu

trafermin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
We investigated the efficacy, safety, and clinical significance of trafermin, a recombinant human fibroblast growth factor (rhFGF… 
Review
2011
Review
2011
Introduction: Basic fibroblast growth factor (bFGF) has been shown to reduce volume in acute ischemic stroke models, and to… 
Highly Cited
2010
Highly Cited
2010
Objective: To present the clinical results of closing chronic tympanic membrane (TM) perforations using basic fibroblast growth… 
2007
2007
BACKGROUND Aplasia cutis congenita (ACC) is a condition in which localized or widespread areas of skin are absent at birth… 
2005
2005
We used trafermin (recombinant human basic fibroblast growth factor) to treat a skin ulcer (diameter, 1 cm; depth, 2 mm) that… 
2005
2005
Trafermin, a form of basic fibroblast growth factor, has been used in Japan since 2001. This study investigates whether it can… 
2004
2004
Aim: Clinical researches using allogeneic CDS, developed in the R & D Center for Artificial Skin of Kitasato University, have… 
Highly Cited
2003
Highly Cited
2003
Objective To present a new method for closing tympanic membrane perforations using basic fibroblast growth factor (bFGF) combined… 
Highly Cited
2002
Highly Cited
2002
Background: Trafermin (basic fibroblast growth factor) has been shown to reduce infarct volume in acute ischemic stroke models… 
1997
1997
The fate of trafermin (recombinant human basic fibroblast growth factor) was examined after intravenous administration of its…